Biotech & MedTech
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
-
David Kerbel on launching Rritual’s premium brand of functional superfoods in Rite Aid stores throughout the USA
In a recent InvestorIntel interview, Tracy Weslosky spoke with David Kerbel, CEO and Director of Rritual Superfoods Inc.…
-
Does Sernova have a cure for Type 1 Diabetes?
There are many impressive companies around the world trying to solve the world’s problems and make this a…
-
Welcome to the Big Leagues.
Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF) has taken a big step forward in its business development…
-
Driving to deliver on their 800M mask coatings per month demand, ZEN Graphene up 746% over the past year
ZEN Graphene Solutions Ltd. (TSXV: ZEN) (‘ZEN’) continues to move at a rapid pace with demand for their…
-
A ‘catch and kill’ mask that offers to get us back to work, welcome SINTX
A classic story of repurposing your tried and true Intellectual Property, allow me to introduce you to SINTX…
-
XPhyto Therapeutics is looking to hit a home run with their innovative medical products and therapies
New therapies and diagnostics in the pharmaceutical and medical industries can be a very lucrative area. To be…
-
XPhyto Therapeutics Hugh Rogers on the fastest and most portable PCR test available
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.…
-
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology
CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is…
-
Warrant Exercise Builds Treasury for Perimeter’s 2021 Commercialization Efforts
Last week, Perimeter Medical Imaging AI, Inc. (TSXV: PINK) announced that approximately 2.35 million warrants subject to an…
